ファーマコビジランスソフトウェア市場：現状分析および予測（2022年～2028年）

世界のファーマコビジランスソフトウェアの市場規模は、予測期間中に約8％の成長率で拡大すると予測されています。ファーマコビジランスは、医薬品副作用の早期発見と自発的な報告に役立ち、医薬品副作用の監視と評価のプロセスであり、効果的な医薬品規制システム、公衆衛生プログラム、臨床研究プログラムの重要な要素となっています。顧客の要件を満たすために、ファーマコビジランスソフトウェアのベンダーは、個別かつ完全なソリューションを提供しています。癌患者の増加がファーマコビジランスにおける報告システムの変化と新技術、そして研究開発および臨床研究プログラムを後押しし、これが同市場の成長を促進しています。

当レポートは、世界のファーマコビジランスソフトウェア市場について調査し、市場の概要とともに、機能性別、提供モード別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場イントロダクション

第2章 調査方法または仮定

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 ファーマコビジランスソフトウェアに対するCOVID-19の影響

第6章 ファーマコビジランスソフトウェア市場の収益、2020年～2028年

第7章 機能別の市場洞察

• 有害事象報告ソフトウェア
• 医薬品安全性監査ソフトウェア
• 問題追跡ソフトウェア
• 完全統合型ソフトウェア

第8章 提供モード別の市場洞察

• オンプレミス配信
• オンデマンド/クラウドベース（SaaS）配信

第9章 エンドユーザー別の市場洞察

• 製薬会社・バイオテクノロジー企業
• CRO
• ビジネスプロセスアウトソーシング会社
• その他

第10章 地域別の市場洞察

• 北米
• 欧州
• アジア太平洋
• その他の地域

第11章 ファーマコビジランスソフトウェア市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第12章 ファーマコビジランスソフトウェアの市場機会

第13章 ファーマコビジランスソフトウェア市場の動向

第14章 需要側と供給側の分析

第15章 バリューチェーン分析

第16章 価格分析

第17章 戦略的洞察

第18章 競合シナリオ

第19章 会社概要

• IQVIA Inc.
• Labcorp Drug Development
• Parexel International Corporation
• Accenture
• Cognizant
• Clario
• Thermo Fisher Scientific Inc.
• ICON plc
• Quanticate
• AB Cube S.A.S.

第20章 免責事項

The global pharmacovigilance software market is expected to grow at a significant rate of around 8% during the forecast period. Pharmacovigilance is useful in the early detection and spontaneous reporting of adverse drug reactions, and it is the process of monitoring and evaluating adverse drug reactions and it is a key component of effective drug regulation systems, public health programs and clinical research programs. To meet the requirements of customers, vendors of pharmacovigilance software offer individualized and complete solutions. These vendors are additionally providing end-to-end solutions, for example, electronic information catch, artificial intelligence, and interoperability, among others to enhance their offerings. In addition, stakeholders in the industry are moving toward the use of modern technology to help them with their pharmacovigilance tasks because of the combined pressures of volume, cost, and the increased demand for analytics.

Changing reporting systems and emerging technology in pharmacovigilance and rising cancer cases boosting the R&D and clinical research programs are driving the market growth. For instance, according to the data published by the American Cancer Society (ACS), in January 2020, around 1.8 million new cancer cases were diagnosed and 606,520 cancer deaths in the United States.

IQVIA Inc., Labcorp Drug Development, Parexel International Corporation, Accenture, Cognizant, Clario, Thermo Fisher Scientific Inc., ICON plc, Quanticate, and AB Cube S.A.S. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst functionality, adverse event reporting software category to witness robust CAGR during the forecast period"

Based on functionality, the market is segmented into adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. Amongst, the adverse event reporting software category is to witness robust CAGR during the forecast period owing to the rising demand for safe medicines and drugs around the world on account of the increasing incidences of adverse drug reactions (ADRs) is contributing to market growth. Apart from this, due to the rapid digitization of clinical trials, there's a rise in the adoption of pharmacovigilance and medicine safety software to ensure the implementation of new methods also drives the market growth during the forecast period.

"Amongst end-users, the pharmaceutical and biotechnology companies to hold a significant share in the market in 2020"

On the basis of end-users, the market is categorized into pharmaceutical and biotechnology companies, contract research organizations, business process outsourcing firms, and others. Among these, the pharmaceutical and biotechnology companies to hold a significant share of the market in 2020. This is mainly due to the extensive research and development efforts by several pharmaceutical companies and these companies are also launching new products which will also contribute to the growth of the market. For instance, Dialog Solutions launched the next generation of pharmacovigilance literature monitoring in 2021.

In addition, multiple adverse events, or adverse reactions force research organizations to turn to pharmacovigilance services for clinical trials, raising the demand for the growth of the market during the forecast period.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the pharmacovigilance software industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to increasing Initiatives undertaken by the governments, investment in the research & development process and adoption of solutions, and the availability of major key market players in the region propelling the growth rate of the market growth during the forecast period. For instance, in 2021, the Open FDA initiative undertaken by the US government provides access to its database through open search-based programs for application developers and scientists.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global pharmacovigilance software market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Pharmacovigilance Software Market
• 2.2. Research Methodology of the Pharmacovigilance Software Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PHARMACOVIGILANCE SOFTWARE MARKET

6 PHARMACOVIGILANCE SOFTWARE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY FUNCTIONALITY

• 7.1. Adverse Event Reporting Software
• 7.2. Drug Safety Audits Software
• 7.3. Issue Tracking Software
• 7.4. Fully Integrated Software

8 MARKET INSIGHTS BY MODE OF DELIVERY

• 8.1. On-Premises Delivery
• 8.2. On-Demand/ Cloud-Based (SaaS) Delivery

9 MARKET INSIGHTS BY END-USERS

• 9.1. Pharmaceutical and Biotechnology Companies
• 9.2. Contract Research Organizations
• 9.3. Business Process Outsourcing Firms
• 9.4. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 PHARMACOVIGILANCE SOFTWARE MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 PHARMACOVIGILANCE SOFTWARE MARKET OPPORTUNITIES

13 PHARMACOVIGILANCE SOFTWARE MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

• 18.1. Competitive Landscape
  • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

• 19.1. IQVIA Inc.
• 19.2. Labcorp Drug Development
• 19.3. Parexel International Corporation
• 19.4. Accenture
• 19.5. Cognizant
• 19.6. Clario
• 19.7. Thermo Fisher Scientific Inc.
• 19.8. ICON plc
• 19.9. Quanticate
• 19.10. AB Cube S.A.S.

20 DISCLAIMER